248 related articles for article (PubMed ID: 15500414)
1. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
Davidson MH
Expert Opin Drug Saf; 2004 Nov; 3(6):547-57. PubMed ID: 15500414
[TBL] [Abstract][Full Text] [Related]
2. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
[TBL] [Abstract][Full Text] [Related]
3. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
McKenney JM
Am J Health Syst Pharm; 2005 May; 62(10):1033-47. PubMed ID: 15901588
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin and the statin wars--the way to peace.
Meyboom RH; Edwards IR
Lancet; 2004 Dec 4-10; 364(9450):1997-9. PubMed ID: 15582043
[No Abstract] [Full Text] [Related]
6. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
García Rodríguez LA; Herings R; Johansson S
Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1218-24. PubMed ID: 20922707
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin: an independent analysis of risks and benefits.
Zipes DP; Zvaifler NJ; Glassock RJ; Gilman S; Muñoz A; Gogolak V; Gordis L; Dedon PC; Guengerich FP; Wasserman SI; Witztum JL; Wogan GN
MedGenMed; 2006 Jun; 8(2):73. PubMed ID: 16926812
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin: renal disorders and rhabdomyolysis.
Prescrire Int; 2007 Apr; 16(88):68-9. PubMed ID: 17458050
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of rosuvastatin.
Olsson GO
Lancet; 2004 Jul 10-16; 364(9429):135. PubMed ID: 15246717
[No Abstract] [Full Text] [Related]
10. Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
Ferdinand KC
Expert Opin Pharmacother; 2005 Sep; 6(11):1897-910. PubMed ID: 16144509
[TBL] [Abstract][Full Text] [Related]
11. The statin wars.
McKillop T
Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
[No Abstract] [Full Text] [Related]
12. The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.
Alsheikh-Ali AA; Ambrose MS; Kuvin JT; Karas RH
Circulation; 2005 Jun; 111(23):3051-7. PubMed ID: 15911706
[TBL] [Abstract][Full Text] [Related]
13. Safety of rosuvastatin.
Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
Kostapanos MS; Milionis HJ; Elisaf MS
Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
[TBL] [Abstract][Full Text] [Related]
15. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
[TBL] [Abstract][Full Text] [Related]
16. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.
Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J
Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845
[TBL] [Abstract][Full Text] [Related]
17. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
McAfee AT; Ming EE; Seeger JD; Quinn SG; Ng EW; Danielson JD; Cutone JA; Fox JC; Walker AM
Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):444-53. PubMed ID: 16761308
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin: winner in the statin wars, patients' health notwithstanding.
Wolfe S
BMJ; 2015 Mar; 350():h1388. PubMed ID: 25787130
[No Abstract] [Full Text] [Related]
19. McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.
Lorenzoni PJ; Silvado CE; Scola RH; Luvizotto M; Werneck LC
Arq Neuropsiquiatr; 2007 Sep; 65(3B):834-7. PubMed ID: 17952291
[TBL] [Abstract][Full Text] [Related]
20. Myopathy caused by a combination rosuvastatin and fenofibrate.
Dedhia V; Munsi SC
J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
[No Abstract] [Full Text] [Related]
[Next] [New Search]